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Abstract NO donors were found to reduce the rate of Ca 2+ 
release from isolated skeletal muscle sarcoplasmic reticulum 
(SR) and the open probability of single ryanodine receptor Ca 2÷ 
release channels (RyRCs) in planar lipid bilayers, and these ef- 
fects were prevented by the NO quencher hemoglobin and re- 
versed by 2-mercaptoethanol. Ca 2÷ release assessed in skeletal 
muscle homogenates was also reduced by NO that was generated 
in situ from L-arginine by endogenous, nitro-L-arginine meth- 
ylester-sensitive NO-synthase. The effect of NO on the RyRC 
might explain NO-induced depression of contractile force in stri- 
ated muscles and, since both RyRC isoforms and NOS isoen- 
zymes are ubiquitous, may represent a wide-spread feedback 
mechanism in Ca 2+ signaling; i.e. Ca-dependent activation of NO 
production and NO-evoked reduction of Ca 2÷ release from intra- 
cellular Ca 2÷ stores. 
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1. Introduction 
Nitric oxide (NO) as a biological messenger molecule has 
been assigned to a number  of cellular functions in a wide variety 
of tissues [1,2], ranging from the regulation of the vascular tone 
to neuronal  plasticity. More recently, NO has been implicated 
in cytokine- and endotoxin-evoked decreases in cardiac con- 
tractility [3,4] and found to depress contracti le function in fast 
skeletal muscle where the brain type constitutive NO-synthase 
(NOS) has been shown to be expressed [5]. The reduction of 
skeletal muscle contracti le force by NO was only partially as- 
cribable to its st imulatory effect on guanylate cyclase [5], the 
often reported signaling pathway in NO action [1,2,6]. Since in 
striated muscles there is a direct relationship between the extent 
of contract ion and the amount  of Ca 2+ released from the sarco- 
plasmic reticulum (SR) through the ryanodine receptor Ca 2+ 
release channel (RyRC), we have asked the question whether 
the Ca 2+ release machinery, i.e. the RyRC, is directly targeted 
by NO. 
Here we report evidence that identifies the Ca 2÷ release mech- 
anism, most likely the RyRC itself, as an NO target in skeletal 
muscle: we show that NO generated either by exogenous NO 
donors or enzymatically from L-arginine in the NO-synthase 
reaction in situ decreases Ca 2+ release activity from SR, which 
parallels an NO-induced reduction in the open probabil i ty of 
single RyRCs fused into planar lipid bilayers. 
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2. Materials and methods 
2.1. Preparations 
Heavy sarcoplasmic reticulum (SR) vesicles were prepared from fast 
twitch muscles of rabbit hind legs by differential [10] and sucrose gradi- 
ent centrifugation [11]. The vesicles isolated by using the differential 
centrifugation protocol were used in the flux, while the gradient-puri- 
fied preparations were used in the single channel studies. The final 
pellets were resuspended in a solution of 75 mM KC1, 150 mM sucrose, 
20 mM MOPS, pH 6.8, also containing a mixture of protease inhibitors 
[12] and stored at -80°C until their use. Skeletal muscle homogenate 
(i.e. a mitochondria-free m mbrane plus cytosol fraction) was prepared 
by an overnight dialysis against 500 volume of the above KCl-sucrose 
solution of the supernatant obtained in the first step of the above 
differential centrifugation protocol. 
2.2. Ca 2+ flux measurements 
Ca > uptake and release were followed by monitoring the absorbance 
changes of arsenazo III at 65(~680 nm using a beam splitter with 
interference filters and a 600 nm cut-on filter in the incoming light path 
as described previously [13 and ref. 17 therein]. The photomultiplier 
signals were amplified with an On-Line Instruments dual channel am- 
plifier which was interfaced through an A/D board with a 386 computer 
for data acquisition. Ca > uptake was initiated by the addition of 8 mM 
acetylphosphate (AcP) to 50-80/zg/ml SR protein suspended in 150 
mM KC1, 20 mM (3-(N-morpholino) propanesulfonic a id (MOPS), 
pH 6.8, 0.5 mM MgC12 and 10/IM arsenazo III (KCI-MOPS medium). 
After the completion of Ca > uptake, Ca 2+ release was induced by 
hand-mixing or, to avoid optical artifacts, rapid mixing of caffeine. In 
Ca 2÷ release experiments carried out with calmodulin-supplemented 
skeletal muscle homogenates, trifluoperazine (TFP) was added together 
with caffeine to prevent calmodulin from influencing the release chan- 
nel [14]. The arsenazo III signal was calibrated to total Ca 2÷ concentra- 
tions in the medium and the non-linear portion of the signals were 
corrected on-line using the Labtech Notebook data-acquisition system. 
2.3. Single channel measurements 
Bilayers consisting of 7:3 phosphatidyl ethanolamine/phosphatidyl 
choline (Avanti Polar Lipids, 50 mg/ml in decane) were formed across 
a 150/,tm aperture in a Teflon chamber. The current measurements and 
data acquisition were performed as described previously [15], except 
that unitary currents were measured with a BLM-120 bilayer amplifier 
(Bio-Logic, France), the leak and capacitance components were elec- 
tronically subtracted and the data were low-pass filtered at 2 kHz using 
a home-made filter device. CsCH3SO3 solutions (i.e. Cs + as current 
carrier) buffered to pH 7.4 with 10 mM MOPS (250 mM cis, 50 mM 
trans) were used to isolate the channel from other ionic conductances 
and to improve signal to noise ratio as described [16]. Single channel 
conductance was determined by measuring the current amplitudes at 
0, +20 and +30 mV holding potential of fully resolved openings. The 
analysis of single channel records was carried out on a 386 computer, 
using the FETCHAN (Axon Instr.) and TRANSIT (Baylor College of 
Medicine, Houston, TX) softwares. 
3. Results and discussion 
The time course of acetylphosphate (AcP)-supported Ca 2+ 
uptake into heavy SR vesicles derived from terminal cisternae 
[17] is shown in Fig. 1A (control, trace a). The inclusion of the 
NO donor  S-nitroso-N-acetylpenici l lamine (SNAP) in the me- 
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Fig. 1. The effects of SNAP on Ca 2÷ uptake and release in isolated SR vesicles. Ca 2+ uptake (traces a~)  initiated by acetylphosphate ddition (AcP, 
20 mM) and release induced by the addition of 6.6 mM caffeine alter completion of Ca 2÷ uptake (traces d-g) were followed spectrophotometrically 
(see section 2). SNAP (10/tM) was either added prior to AcP (traces b,c) or where indicated (traces e-g). Ruthenium red (5/IM) was present in trace 
c, oxygenated hemoglobin (Hb, 20/~M) in trace f. Ca-ionophore A23187 (2 ¢tM) was added where indicated. Representative traces are shown. 
dium (trace b) resulted in an apparent increase in the rate of 
the second slow phase of Ca 2+ accumulation, without having 
any appreciable ffect on its initial rate. This suggests that 
SNAP, instead of directly influencing the SR Ca 2+ pump, was 
most likely to reduce the rate of Ca 2+ release. That  this was 
indeed the case is indicated by the findings that in the presence 
of the Ca 2+ release blocker ruthenium red [10,17] the rates of 
Ca 2+ uptake with and without SNAP were indistinguishable 
(not shown) and that, as il lustrated in Fig. 1 B, the rate of Ca 2+ 
release induced by caffeine was significantly lowered in the 
presence of SNAP (trace e, as compared to the control trace 
d). The addit ion of  the NO-quencher hemoglobin to the me- 
dium prior to SNAP addit ion (trace f) prevented the NO donor 
from decreasing SR Ca 2+ release activity, indicating that the 
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Fig. 2. The kinetics of SNAP-inhibition of Ca -,+ release. The measure- 
ments were carried out as described in the section 2. Caffeine (6.6 mM 
final concentration) was rapidly mixed to SR vesicles that were pre- 
loaded with Ca 2÷ as shown in Fig. 1. The released (total) Ca 2+ is 
expressed as the percentage of the total luminal Ca 2+ that is releasable 
upon A23187 addition (see also Fig. 1B). The traces are the averages 
of 22 and 16 individual sweeps of control experiments and those with 
SNAP (10 ¢tM), respectively, and were collected from experiments with 
2 separate SR preparations. Dotted lines are the best fits to the linear 
portion of the time course and the computed slopes are shown. Initial 
rates were (as computed by fitting of exponentials; not shown): 7.51 and 
5.83 (%/s) for control and SNAP, respectively. 
principal agent responsible for release inhibit ion was NO liber- 
ating from SNAR This is also supported by the findings that 
other NO donors with rather different chemical structure (3- 
morphol ino-sydnonimine,  SIN-1 and sodium nitroprusside, 
SNP) were also found to inhibit SR Ca 2+ release (not shown). 
Fig. 2 depicts averaged traces of caffeine-induced Ca 2+ re- 
lease in the absence and presence of SNAP. These traces were 
recorded as those in Fig. 1, except that a Durrum two-syringe 
rapid mixer was used to avoid optical artifacts due to mixing. 
SNAP only caused a slight reduction in the initial rate (22%), 
but reduced the rate in the second slow phase of Ca 2+ release 
by about 65% (see the dotted lines in Fig. 2 that are best fits 
to the linear port ion of the time courses). The same type of 
kinetic effects, i.e. slight reduction of the initial, but marked 
decrease in the second phase, were observed with SIN-1 and 
SNP as NO donors (not shown). The analysis of the release 
time courses (to be published separately) with and without 
SNAP suggests that the mechanism of NO-inhibit ion is the 
promot ion of channel inactivation, rather than the blockage of 
the release channel. 
Kobzik et al. [5] found that the Ca2+/calmodulin-dependent 
constitutive brain isoform of nitric oxide synthase (NOS) is 
expressed in fast skeletal muscle. This has provided a possibility 
Table 1 
Effect of SNAP on single RyRC behavior and its removal by 2-mercap- 
toethanol 
Parameter Control SNAP SNAP+ 1.4 mM 
2-mercaptoethanol 
Open probability* 
(%) 10.43 + 0.82 4.1 + 0.59 12.31 + 4.13 
Average open 
time** (ms) 1.21 _+ 0.16 0.85 +- 0.07 1.28 _+ 0.02 
Average number of 
openings/ 
segment*** 30.9 -+ 1.3 16.57 _+ 2.2 46.0 _+ 12.8 
t-test: for SNAP vs. Control: *P < 0.001; **P < 0.1; ***P < 0.01 (n, i.e. 
number of independent experiments, =4); for SNAP + 2-mercaptoetha- 
nol vs. Control: *'**'*** - n.s. (n = 4). Total of 484 segments for con- 
trol, 974 for SNAP and 243 for SNAP+2 mercaptoethanol. Each 
segment was 409.6 ms long. The effects of SNAP developed within few 
seconds after addition. 
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Fig. 3. The effects of NO generated by endogenous NOS on Ca  2+ uptake and release in skeletal muscle homogenates. AcP (at the arrow) was added 
to 5-fold diluted (0.8 1.2 mg/ml) homogenate in KC1-MOPS medium supplemented with 10/Ag/ml calmodulin, 5/AM FAD, 5/AM FMN, 10/AM 
tetrahydro-L-biopterin, 0.1 mM NADPH (tracec, marked as -Arg) plus 0.5 mM L-arginine (trace b, d and e, marked as +Arg). After completion 
of Ca 2+ uptake, caffeine (6.6 mM) and TFP (400 pM) were added (at the arrow). In control experiments with TFP present, he Ca 2÷ release flux was 
completely blocked by 5/AM ruthenium red (not shown), k-NAME (2.5 mM) was added before Ca 2+ uptake was initiated (trace e, marked as +Arg, 
NAME). Representative traces are shown. 
to test whether SR Ca 2+ release is also responsive to en- 
dogenously generated NO. Thus, we studied SR Ca 2+ uptake 
(Fig. 3A) and release (Fig. 3B) in skeletal muscle homogenates 
supplemented with NOS substrates (e-arginine, NADPH) ,  
cofactors (FMN,  FAD, tetrahydro-e-biopterin) and calmod- 
ulin [18]. When e-arginine was omitted from the medium, Ca 2+ 
uptake was found to be slower (trace a as compared to trace 
b), while Ca z+ release induced by caffeine (plus TFP, see section 
2) was significantly faster (trace c as compared to trace d). 
Furthermore,  the addit ion of the NOS inhibitor nitro-L-argin- 
ine methylester (L-NAME) was apparently able to antagonize 
the effect of e-arginine (trace e vs. trace d), i.e. increased the 
release rate close to control (-L-arginine) levels. These results 
indicate that NO generated in situ from L-arginine in a L- 
NAME-sensit ive NOS reaction was also capable of reducing 
Ca 2+ release rate. 
The above results obtained from flux measurements suggest 
that NO might inhibit the RyRC, the principal Ca 2+ release 
pathway in striated muscles. To directly test this possibility, 
sucrose gradient purified SR vesicles were fused into planar 
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Fig. 4. Inactivation of a single RyRCs by SNAP and its reversal by 2-mercaptoethanol (A). The channel was activated by 20/AM Ca 2÷ and single 
channel currents were recorded at +30 mV (left), then 0.1 mM SNAP was added (middle) which was followed by the addition of 1.4 mM 
2-mercaptoethanol in the continuing presence of SNAP (right). B: The effect of ryanodine. Control channel currents hown in A had an amplitude 
of 19.5 pA and short mean open time. About 30 s after the addition of 10/AM ryanodine, single channel currents abruptly changed to ones with 
amplitude of 8.9 pA and long open time (18). 
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lipid bilayers [15,19] and unitary Cs ÷ currents of single RyRCs 
[16] were studied in the presence and the absence of NO donors. 
The single channels in the bilayer were identified by both their 
conductance (408 + 12 pS) and their typical response [19] to 
ruthenium red (not shown) as well as to ryanodine (Fig. 4B). 
Fig. 4A illustrates a set of consecutive pisodes in representa- 
tive channel records before and after the addition of SNAP (to 
the cis chamber) and after a subsequent addition of 2-mercap- 
toethanol. As seen from the records and the data in Table l, 
which summarizes the averages of the channel parameters 
measured in 4 separate xperiments, SNAP caused a significant 
decrease in the number of openings which resulted in a signifi- 
cant (about 60%) decrease in the overall open probability. 
(Note that the mean open time was not significantly changed 
by SNAR) Mercaptoethanol added after SNAP apparently 
resulted in a recovery of both the number of openings and open 
probabilities to control evels (Table 1) and, when added before 
SNAP (not shown), it prevented the NO donor-induced e- 
crease in open probability without having any appraciable f- 
fect on the control. This strongly suggests that the probable 
mechanism of NO action is the modification of highly reactive 
cysteine residues of RyRC [9], which are known to alter the 
kinetics properties of skeletal SR Ca 2+ release [8,9]. Similar 
single channel results were obtained with another NO donor, 
SIN-1 (not shown). 
In summary, NO donor compounds that are known to gen- 
erate NO in aqueous olutions inhibit Ca 2+ release from iso- 
lated SR vesicles in an NO-quencher (hemoglobin) preventable 
fashion. Furthermore, in skeletal muscle homogenates, Ca 2÷ 
release activity is decreased when the medium was supple- 
mented with e-arginine (in the presence of other substrates and 
cofactors of the Ca2+/calmodulin-dependent NOS). This effect 
of c-arginine was prevented by L-NAME, the inhibitor of NOS. 
These together indicate that NO inhibits SR Ca 2+ release. Since 
the NO donor SNAP was also found to decrease the open 
probability of single RyRCs incorporated into planar lipid bi- 
layers, the effect of NO on SR Ca 2÷ release is most likely due 
to its influence on the RyRC itself. Kinetic considerations sug- 
gest that the mechanism of NO action on the release channel 
is promoting channel inactivation. 
In control experiments (not shown), we could rule out the 
possibility that an NO-activated cGMP signaling pathway 
would be responsible for the NO action we describe here, since: 
(i) exogenously added cGMP (up to 50/~M) induced no inhibi- 
tion of SR Ca -,+ release (in either isolated SR vesicles or in 
homogenates) and (ii) radio-immune-assay for cGMP showed 
no evidence for the presence of GTP contamination i either 
preparations (note that the homogenate preparations were 
dialyzed before use). Therefore, we conclude that NO directly 
affects the SR Ca 2+ release machinery, i.e. the RyRC. 
The effect of NO on SR Ca z+ release could account for the 
previously observed NO-induced force reduction in both skele- 
tal [5] and cardiac muscle [3,4]. Whether or not NO has a role 
in regulating muscle contraction on a twitch-by-twitch (or beat- 
by-beat) basis is too early to speculate. It is worthwhile to note, 
however, that, since the occurrence of both the RyRCs [20] and 
the constitutive form of NOS [1,2] appears to be ubiquitous, the 
influence of NO on the release channel together with the known 
Ca /calmodulin-de- Ca-requirement of NO-generation via the 2+ 
pendent isoform of NOS [1,2,18] might represent an important 
regulatory feedback loop, in which Ca 2+ activates the produc- 
tion of NO that, in return, controls the extent of the RyRC- 
mediated Ca 2+ rise in the cell. In this respect, it will be impor- 
tant to test how the inositol 1,4,5-trisphosphate-controlled Ca 2+ 
release process, which is also known to be responsive to -SH 
reagents [21], would be influenced by NO. The possible opera- 
tion of the above feedback mechanism is especially intriguing, 
when a seemingly antagonistic relationship between the stimu- 
lant Ca 2+ and the tranquilizer NO is considered in the light of 
the proposed retrograde messenger role of NO in neurons 
[22,23] and its muscle relaxant effect in smooth [1,2] and striated 
muscles [3 5]. 
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